ClinicalTrials.gov record
Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator
COMPLETED · NCT01926847
Trial record
NCT IDNCT01926847
Status
COMPLETED
Study type
INTERVENTIONAL
Phase
PHASE2
Enrollment
23
Conditions
Raynaud Disease
Interventions
Riociguat (Adempas, BAY63-2521), Placebo
Locations
Cologne, North Rhine-Westphalia, Germany
Indexed topics
Last update
2014-06-13